AtriCure

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 2000-11-01

Employees: 1.2K

Market Cap: -

Website: http://www.atricure.com

Introduction: AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Clinical Trials

CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF

Not Applicable

Withdrawn

Conditions: Atrial Fibrillation

Interventions: Device: Convergence Of Epicardial And Endocardial RF Ablation

First Posted Date: 2020-01-27

Last Posted Date: 2022-07-27

Lead Sponsor: AtriCure, Inc.

Registration Number: NCT04239534

Locations: 🇺🇸
Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸
Heart Center Research LLC, Huntsville, Alabama, United States
🇺🇸
Medstar Washington Hospital Center, Washington, District of Columbia, United States

and more 7 locations

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

Not Applicable

Active, not recruiting

Conditions: Persistent Atrial Fibrillation
Atrial Fibrillation (AF)
Longstanding Persistent Atrial Fibrillation

Interventions: Device: AtriCure CryoICE & AtriClip LAA Exclusion

First Posted Date: 2018-11-07

Last Posted Date: 2024-10-14

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 150

Registration Number: NCT03732794

Locations: 🇺🇸
West Virginia University, Morgantown, West Virginia, United States
🇺🇸
Northwestern Medicine, Chicago, Illinois, United States
🇺🇸
Franciscan Health, Indianapolis, Indiana, United States

and more 12 locations

The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)

Not Applicable

Completed

Conditions: Pain

Interventions: Device: Cryoanalgesia
Drug: Standard of Care

First Posted Date: 2016-10-04

Last Posted Date: 2020-09-04

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 84

Registration Number: NCT02922153

Locations: 🇺🇸
University of Southern California (USC), Los Angeles, California, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States

and more 2 locations

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

Phase 4

Completed

Conditions: Post-Operative Atrial Fibrillation

Interventions: Device: AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems
Drug: Anticoagulation Therapy

First Posted Date: 2016-03-08

Last Posted Date: 2021-11-24

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 562

Registration Number: NCT02701062

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
United Heart & Vascular Clinic, Saint Paul, Minnesota, United States
🇺🇸
Cardiology Associates Research, Tupelo, Mississippi, United States

and more 19 locations

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation

Not Applicable

Completed

Conditions: Persistent and Longstanding Persistent Atrial Fibrillation
Atrial Fibrillation

Interventions: Device: AtriCure Bipolar System
Device: Standard Endocardial Ablation with Catheter
Device: AtriClip® PRO LAA Exclusion System
Device: Repeated Endocardial ablation(s)
Device: Endocardial Ablation with Catheter

First Posted Date: 2016-03-01

Last Posted Date: 2024-10-11

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 146

Registration Number: NCT02695277

Locations: 🇨🇿
Dr Tomáš Ostřížek, Brno, Czechia
🇨🇿
Czech Budejovice Hospital, Inc., Budweis, Czechia
🇩🇪
Schüchtermann-Schiller'sche Kliniken Herzzentrum Osnabrück, Bad Rothenfelde, Germany

and more 9 locations

aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation

Not Applicable

Conditions: Atrial Fibrillation

Interventions: Device: Pulmonary Vein Isolation
Device: LARIAT + PVI

First Posted Date: 2015-08-03

Last Posted Date: 2021-09-05

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 600

Registration Number: NCT02513797

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Johns Hopkins, Baltimore, Maryland, United States

and more 50 locations

Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach

Not Applicable

Completed

Conditions: Persistent or Longstanding Persistent Atrial Fibrillation
Atrial Fibrillation

Interventions: Device: AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation

First Posted Date: 2015-03-20

Last Posted Date: 2024-12-19

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 90

Registration Number: NCT02393885

Locations: 🇺🇸
Cedars-Sinai Heart Institute, Los Angeles, California, United States
🇺🇸
Saint Alphonsus Regional Medical Center, Boise, Idaho, United States
🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States

and more 14 locations

LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RS

Not Applicable

Completed

Conditions: Atrial Appendage

Interventions: Device: LARIAT RS Suture Delivery Device

First Posted Date: 2014-02-11

Last Posted Date: 2020-01-09

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 58

Registration Number: NCT02059707

Locations: 🇵🇱
Jagiellonian University (John Paul II) Hospilal, Krakow, Poland

Stroke Feasibility Study

Phase 1

Completed

Conditions: AFib
Atrial Fibrillation

Interventions: Device: AtriClip LAA Exclusion Device

First Posted Date: 2013-11-28

Last Posted Date: 2016-12-14

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 13

Registration Number: NCT01997905

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸
Aspirus, Wausau, Wisconsin, United States
🇺🇸
St. Helena Hospital, St. Helena, California, United States

and more 4 locations

Left Atrial Appendage Exclusion Study

Not Applicable

Completed

Conditions: Atrial Appendage

Interventions: Device: LARIAT Suture Delivery Device

First Posted Date: 2013-11-14

Last Posted Date: 2020-01-09

Lead Sponsor: AtriCure, Inc.

Target Recruit Count: 96

Registration Number: NCT01983605

Locations: 🇵🇱
Jagiellonian University (John Paul II) Hospital, Krakow, Poland

Home Terms & Conditions Privacy Policy